专利从业者可以从Nalpino Pharmaceuticals，股份有限公司诉Actavis Laboratories FL，股份有限公司中学到什么。

{"title":"专利从业者可以从Nalpino Pharmaceuticals，股份有限公司诉Actavis Laboratories FL，股份有限公司中学到什么。","authors":"L. Genieser","doi":"10.1093/jiplp/jpab068","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"What patent practitioners can learn from Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.\",\"authors\":\"L. Genieser\",\"doi\":\"10.1093/jiplp/jpab068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":44529,\"journal\":{\"name\":\"Journal of Intellectual Property Law & Practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2021-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Intellectual Property Law & Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jiplp/jpab068\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Intellectual Property Law & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jiplp/jpab068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"LAW","Score":null,"Total":0}